A practical, scenario-based guide to evaluating wound care suppliers. Written from the perspective of an experienced administrative buyer, this article breaks down the selection process into three distinct business scenarios and explains why total cost of ownership matters more than unit price.
Read MoreAn admin buyer shares the hard-learned lesson that the lowest quote for supplies like Mepilex or surgical drapes often hides the highest total cost, arguing for transparency and reliability over upfront savings.
Continue readingA practical, step-by-step checklist for administrative buyers evaluating medical device suppliers like Molnlycke Health Care. Covers verification, compliance, and delivery certainty.
Continue readingAn emergency specialist shares a real story about a critical same-day delivery for a hospital OR, highlighting the value of transparency and preparedness in medical supplies procurement.
Continue readingA quality inspector explains why focusing on specs alone leads to vendor failures. Learn how Mölnlycke’s systematic approach—from Safetac to compliance—protects against hidden defects that batch testing misses.
Continue readingA procurement professional shares costly mistakes made while ordering Mölnlycke wound care products. Learn how to avoid common errors with Mepilex, Mepiform, and Melgisorb, plus a checklist to prevent wasted budget.
Continue readingAn emergency specialist explains why Mölnlycke's Mepiform with Safetac technology is the go-to scar management solution for patients using CPAP machines, drawing from clinical experience and real-world urgency.
Continue readingA buyer's guide to Mölnlycke's flagship dressing technology from an administrative perspective. Honest about where it shines and where you may be better served by alternatives.
Continue readingA procurement manager's comparison of Molnlycke's Safetac-based wound care products against alternative suppliers, focusing on total cost, hidden fees, and small-order friendliness.
Continue readingAn emergency specialist argues that prioritizing unit price over total clinical value in hospitals is a dangerous mistake, using concrete examples from wound care and infection control.
Continue reading